05 February 2019
A number of revisions have been made to the Guide to Global Fund Policies on Procurement and Supply Management of Health Products (PSM Guide).
The guide has been updated to provide clarification on language regarding TRIPS flexibilities; reflect changes to the WHO mechanism on prequalification for vector control and align the guide with other health products practices; and add new guidance on the adoption of GS1 Global Data Standards.
In addition, it improves the reporting mechanism for adverse drug reaction and non-compliance to a National Regulatory Authority and the Global Fund; as well as clarifies the definition of a Stringent Regulatory Authority and price and quality reporting.
The updated guide also requires Principal Recipients to designate a quality assurance focal point.